We reported earlier that continuous feeding of
1,4-phenylenebis(methylene)selenocyanate (p-XSC) inhibited lung
tumor induction by the tobacco-specific
nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the A/J mouse (El-Bayoumy et al.,
Carcinogenesis, 14, 1111-1113, 1993). The present investigation was designed to determine whether p-XSC inhibits pulmonary
neoplasia induced by NNK in female A/J mice during the initiation phase of
carcinogenesis or during the post-initiation phase. The naturally occurring
selenomethionine was also included in this study. Doses higher than 4 p.p.m. of
selenomethionine can induce toxic effects, therefore, dietary supplementation of this compound was selected at a dose level of 3.75 p.p.m. However, we were able to give p-XSC at
selenium levels of 7.5 and 15 p.p.m., as mice can tolerate such doses in this form without any adverse effects. NNK was given by a single i.p. injection at dose of 10 micromol in 0.1 ml of saline.
Selenomethionine did not show chemopreventive activity when administered in either phase of
tumorigenesis. In contrast, p-XSC significantly reduced lung
tumor multiplicity regardless of whether it was given during the initiation phase of
tumorigenesis (P = 0.0009 at both levels of
selenium) or post-initiation (P = 0.0009 at 15 p.p.m. and P = 0.036 for 7.5 p.p.m.). This is the first report describing that the synthetic organoselenium compound, p-XSC, can effectively block and suppress chemically (NNK)-induced lung
tumor development in mice.